Allosteric modulators of metabotropic glutamate receptors
US7834035B2 · kind B2 · utility
27Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2004 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Aug 8, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new compounds of formula (I) wherein A, B, P, Q, W, R1 and R2 are defined in the description; invention compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.